A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Conditions:   Sarcoma;   Carcinoma;   Digestive Cancer;   Breast Cancer;   Lung Cancer;   Brain Cancer;   Melanoma;   Gynecologic Cancer;   Head and Neck Cancer;   Kidney Cancer Intervention:   Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors:   Shanghai Yunying Medical Technology;   Linyi Central Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials

Herpes Zoster Hospitalizations in Italy
Conditions:   Herpes Zoster;   Comorbidities and Coexisting Conditions Intervention:   Other: Hospitalization Sponsors:   University of L'Aquila;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials